Cite
First-line therapy for multiple myeloma(MM): results from the second interim analysis of the real-world, international, non-interventional EMMOS study
MLA
Mohty, Mohamad, et al. First-Line Therapy for Multiple Myeloma(MM): Results from the Second Interim Analysis of the Real-World, International, Non-Interventional EMMOS Study. Jan. 2014. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.57a035e5b1ae..8308622d9e4da63d4a2cff24deca39ff&authtype=sso&custid=ns315887.
APA
Mohty, M., terpos, E., Mateos, maria-V., Palumbo, A., Lejniece, S., beksac, M., Bakadja, M. A., Legiec, ojchiech, Dimopoulos, M., Stankovic, S., Duran, M. S., De tefano, V., Kochkareva, Y., Laane, E., Berthou, C., Salwender, H., Masliak, Z., Peculiunas, V., Willenbacher, W., … horet-Bauchet, F. B. M. (2014). First-line therapy for multiple myeloma(MM): results from the second interim analysis of the real-world, international, non-interventional EMMOS study.
Chicago
Mohty, Mohamad, Evangelos terpos, maria-Victoria Mateos, Antonio Palumbo, Sandra Lejniece, Meral beksac, Mohamed Amine Bakadja, et al. 2014. “First-Line Therapy for Multiple Myeloma(MM): Results from the Second Interim Analysis of the Real-World, International, Non-Interventional EMMOS Study,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.57a035e5b1ae..8308622d9e4da63d4a2cff24deca39ff&authtype=sso&custid=ns315887.